Biome Australia Secures Ethics Approval for 240-Patient BMB18 Probiotic Trial
Video
Biome Australia is a pioneering health technology company dedicated to developing, commercializing, and marketing innovative live biotherapeutics and complementary medicines. With a strong focus on evidence-based solutions, the company aims to leverage microbiome research to prevent disease, improve health outcomes, and enhance quality of life for individuals. Their commitment to scientific rigor and clinical validation sets them apart in the healthcare and wellness industry.
The company’s flagship brand, Activated Probiotics, represents their core mission of creating precision, practitioner-only probiotic products. By partnering with leading microbiome research organizations, Biome Australia develops targeted therapeutic solutions that address specific health challenges. Their approach combines cutting-edge scientific research with practical, accessible healthcare interventions that can be tailored to individual patient needs.
As a publicly listed company on the Australian Securities Exchange (ASX:BIO), Biome Australia maintains transparency and engagement with its investors through an open Investor Hub. The company not only focuses on product development but also emphasizes clear communication with shareholders and the broader healthcare community. Their strategic vision involves continuous innovation in microbiome-based health solutions, positioning themselves at the forefront of a rapidly evolving field of medical research and personalized healthcare.